New corporate identity reflects the Company’s mission to develop novel medicines to modulate filamin A and address unmet needs in treating ...

In our series of letters from African journalists, Ghanaian Elizabeth Ohene considers the call of Uganda's President Yoweri Museveni for people to eat the humble cassava as the price of wheat soars ...

Cassava Sciences rebrands to Filana Therapeutics (FLNA) on March 11, 2026, focusing on filamin A CNS therapies for TSC epilepsy—get the latest update.

Dublin, Jan. 17, 2025 (GLOBE NEWSWIRE) -- The "Cassava Market Size, Share & Trends Analysis by Product, Type, Application, and Region, 2024-2030" report has been added to ResearchAndMarkets.com's ...

Cassava Technologies has launched a national sovereign cloud platform aimed at helping African governments deploy artificial ...

Cassava Sciences' Alzheimer's drug simufilam failed its Phase 3 trial, causing the stock to plummet ~90% and trade near book value. The company's decision to discontinue other simufilam trials signals ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Facing charges from the Securities and Exchange Commission for misleading claims ...

Add Yahoo as a preferred source to see more of our stories on Google. A grower shows off his lush cassava garden. Stephen Wooding, CC BY-ND The three staple crops dominating modern diets – corn, rice ...

The three staple crops dominating modern diets – corn, rice and wheat – are familiar to Americans. However, fourth place is held by a dark horse: cassava. Over the course of millennia, Indigenous ...